← Browse by Condition
Medical Condition

leukemia lymphocytic

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT05254743 Phase 3
Recruiting

A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Enrollment
662 pts
Location
United States, Argen...
Sponsor
Loxo Oncology, Inc.
View Trial →